|
|
 |
|
Viewing report
|
|
|
|
Cancer Therapies - Global Strategic Business Report
Global Industry Analysts, Inc., Feb 2009, Pages: 694
This report analyzes the global market for Cancer Therapies in US$ Billion. The specific product segments analyzed are Chemotherapy, Targeted Therapy, Hormonal Therapy, and Immunotherapy. Annual forecasts for the global market is provided for the period of 2006 through 2015. A six-year historic analysis is also provided.
The report profiles 207 companies including many key and niche players worldwide such as Abraxis BioScience, Inc., Amgen, Inc., AstraZeneca PLC, Bayer Schering Pharma, Biogen Idec Inc., Bristol-Myers Squibb Company, Celgene Corporation, Cell Therapeutics, Inc., Cephalon, Inc., Chugai Pharmaceutical Co., Ltd., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Genentech, Inc., Genzyme, GlaxoSmithKline, Imclone Systems, Inc., Merck KGaA, Novartis AG, Ortho Biotech Products, L.P, OSI Pharmaceuticals, Inc., Pfizer, Sanofi-Aventis, Schering Plough Corporation, Seattle Genetics, Inc., Takeda Pharmaceutical Company Limited, and Wyeth. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.
For information on site licence pricing please click on Enquire before buying
Customers who bought this item also bought
Commercial Insight: Antihormonal Cancer Therapies
Biomarker Technology Platforms for Cancer Diagnoses and Therapies
Innovative and Targeted Cancer Therapies: Key Technologies, New Applications and Leading Players
Pipeline Insight: Molecular Targeted Cancer Therapies: Can Anything Else Revolutionize the Market?
Strategic Perspectives 2002: Cancer Adjunct Therapies
Stakeholder Insight: Adjunct Therapies in Breast Cancer
Pipeline Insight: Molecular Targeted Cancer Therapies - More Pipeline Activity, Less Product Differentiation
European Testosterone Replacement Therapies Markets
Prostate Cancer Therapeutics - Global Strategic Business Report
The Cancer Market Outlook to 2012
Analytical Tool - Breast Cancer
Analytical Tool - Prostate Cancer
|
|
|
|
